Picture of MindMaze Therapeutics Holding SA logo

MMTX MindMaze Therapeutics Holding SA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Swiss stocks - Factors to watch on Nov 9

ZURICH/BERLIN, Nov 9 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Tuesday:
   
    RICHEMONT  CFR.S 
    Artisan Partners, a shareholder in Richemont  CFR.S , said
that there is significant unrecognized value within the company
related to its e-commerce business, which is currently
loss-making.
    
    SWISS LIFE HOLDING AG  SLHN.S 
    Swiss Life fee income rose 15% in local currency to 1.64
billion Swiss francs ($1.80 billion) in the first nine months of
the year as all divisions contributed to the rise, Switzerland's
biggest life insurer said on Tuesday, adding it was on track to
meet or beat 2021 targets.  urn:newsml:reuters.com:*:nL8N2S013K
    
    COMPANY STATEMENTS    
    * WISeKey  WIHN.S  said it has joined forces with SUNX to
make its NFT platform climate-friendly  WIHN.S 
    * Schlatter Industries  STRN.S  said Schlatter Group won an
order worth for almost 10 million Swiss francs for a production
plant of reinforcement mesh  STRN.S 
    * PSP Swiss Property  PSPN.S  slightly raised its full-year
outlook and said it now expects an EBITDA above 275 million
francs for the year excluding gains or losses on real estate
investments, after reporting 431.0 million francs in net income
for the first nine months.  PSPN.S 
    * Montana Aerospace  AERO.S  confirmed its full-year
guidance and reporting nine-month adjusted EBITDA of 43.0
million euros.  AERO.S 
    * Relief Therapeutics  RLFB.S  said it was implementing 
transitions within its commercial organisation to further
develop the company.  RLFB.S 
    
    ANALYST RATINGS
    MOLECULAR PARTNERS AG  MOLN.S : CREDIT SUISSE ASSUMES
COVERAGE WITH NEUTRAL RATING AND CHF 17 TARGET PRICE
    KLINGELNBERG AG  KLIN.S : CREDIT SUISSE CUTS TARGET PRICE TO
EUR 23.5 FROM EUR 28
    IDORSIA LTD  IDIA.S : CREDIT SUISSE ASSUMES COVERAGE WITH
OUTPERFORM RATING AND CHF 31 TARGET PRICE
    VIFOR PHARMA AG  VIFN.S : CREDIT SUISSE ASSUMES COVERAGE
WITH OUTPERFORM RATING AND CHF 141 TARGET PRICE
    SIEGFRIED HOLDING AG  SFZN.S : CREDIT SUISSE ASSUMES
COVERAGE WITH OUTPERFORM RATING AND CHF 1086 TARGET PRICE
    POLYPEPTIDE GROUP AG  PPGN.S : CREDIT SUISSE ASSUMES
COVERAGE WITH NEUTRAL RATING AND CHF 138 TARGET PRICE
    BACHEM HOLDING AG  BANB.S : CREDIT SUISSE ASSUMES COVERAGE
WITH NEUTRAL RATING AND CHF 738 TARGET PRICE
    
    ECONOMY
    No major Swiss economic data scheduled.

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on MindMaze Therapeutics Holding SA

See all news